Bosentan is a dual endothelin receptor antagonist used to treat pulmonary arterial hypertension by inhibiting endothelin, a protein that constricts blood vessels. It is grouped under the following drug class(es): Vasodilating agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Tracleer, Benzenesulfonamide, 4-(1, 1-dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)(2 and 2′-bipyrimidin)-4-yl)-. Its PubChem CID is 104865.
Bosentan
| CAS No | 147536-97-8 |
|---|---|
| Molecular Formula | C27H29N5O6S |
| Molecular Weight | 551.63 g/mol |
| Synonyms | 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Bosentan is a dual endothelin receptor antagonist used to treat pulmonary arterial hypertension by inhibiting endothelin, a protein that constricts blood vessels.
The listed CAS number is 147536-97-8.
The listed molecular formula is C27H29N5O6S.
The listed molecular weight is 551.63 g/mol.
4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide.
The source lists Tracleer, Benzenesulfonamide, 4-(1, 1-dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)(2 and 2'-bipyrimidin)-4-yl)-.